Safety and efficacy of gefitinib for treatment of advanced non-small cell lung cancer

JM Xu, YM Li, XQ Liu, WW Yang… - Zhonghua Zhong liu za zhi …, 2007 - europepmc.org
Objective To evaluate the safety and efficacy of gefitinib as second-line or even third-line
treatment for previously treated patients with locally advanced or metastatic non-small cell …
被引用次数：1 相关文章

Safety and efficacy of gefitinib for treatment of advanced non-small cell lung cancer

J XU, Y LI, X LIU, Y ZHANG, Y HAN… - Chinese Journal of …, 2007 - pesquisa.bvsalud.org
ABSTRACT< p>< b> OBJECTIVE</b> To evaluate the safety and efficacy of gefitinib as
second-line or even third-line treatment for previously treated patients with locally advanced …

Safety and efficacy of gefitinib for treatment of advanced non-small cell lung cancer

J Xu, Y Li, X Liu, Y Zhang, Y Han… - Zhonghua zhong liu …, 2007 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the safety and efficacy of gefitinib as second-line or even third-line
treatment for previously treated patients with locally advanced or metastatic non-small cell …

Safety and efficacy of gefitinib for treatment of advanced non-small cell lung cancer.

J XU, Y LI, X Liu, Y Zhang, Y Han… - Chinese Journal of …, 2007 - wprim.whocc.org.cn
Western Pacific Region Index Medicus 中文 | English Western Pacific Region Index Medicus
Home | Help | Contact Return Safety and efficacy of gefitinib for treatment of advanced …

Safety and efficacy of gefitinib for treatment of advanced non-small cell lung cancer

J XU, Y LI, X LIU, Y ZHANG, HAN Yu… - Chinese Journal of …, 2007 - pesquisa.bvsalud.org
ABSTRACT< p>< b> OBJECTIVE</b> To evaluate the safety and efficacy of gefitinib as
second-line or even third-line treatment for previously treated patients with locally advanced …